Prognostic value of CD4+T cell in patients with severe COVID-19

Xuesong Wen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongying Zhang(Huaian First People’s Hospital), Peng Lei(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guoqiang Cai(University of Alabama at Birmingham), Xiao‐Wei Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yue Chen(Anhui Medical University), Bin He(Soochow University), Lei Gao(Fujian Medical University), Dan Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shu Qin(Shanxi Agricultural University), Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Unknown
May 18, 2020
10.22541/au.158981149.91322918
Cited by 0

Related Papers

Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
|Journal of Pharmacology and Experimental Therapeutics|2014|111
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
|Journal of Molecular Medicine|2018|106
Repetitive transcranial magnetic stimulation as an alternative therapy for dysphagia after stroke: a systematic review and meta-analysis
|Clinical Rehabilitation|2016|94
TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
|Cell Death and Disease|2020|93